The Menopause Guidelines In Plain English

This document serves as the primary guidebook for doctors and healthcare professionals on how to safely and effectively prescribe hormone therapy (HT) to women going through menopause.

At its core, the statement concludes that hormone therapy remains the single most effective treatment for the classic symptoms of menopause, such as hot flashes, night sweats, and vaginal dryness, and it is highly effective at preventing bone loss. However, the report stresses that hormone therapy is not a "one-size-fits-all" treatment; the safety and benefits depend heavily on a woman’s age, her medical history, and exactly how the hormones are taken.

Here is a comprehensive breakdown of the key takeaways from the 2022 NAMS Position Statement.

The "Golden Rule" of Timing and Age

One of the most important concepts in the position statement is the "timing hypothesis." This rule dictates that the benefits of hormone therapy heavily outweigh the risks depending on when a woman starts taking it.

• The "Safe" Window: For healthy women who are under the age of 60, or who are within 10 years of the onset of menopause, the benefits of hormone therapy generally outweigh the risks. In this group, hormone therapy is highly effective at relieving bothersome symptoms and protecting bone health without significantly raising the risk of serious health events.
• The "Risky" Window: If a woman starts hormone therapy for the first time when she is over the age of 60, or if it has been more than 10 to 20 years since her menopause began, the risks start to outweigh the benefits. In this older group, starting hormone therapy can increase the absolute risks of coronary heart disease, strokes, blood clots, and dementia.

What Does Hormone Therapy Actually Treat?

The FDA has approved hormone therapy for four specific primary uses:

• Vasomotor Symptoms (Hot Flashes and Night Sweats): Hormone therapy is considered the gold standard and first-line treatment for moderate to severe hot flashes and night sweats, reducing their frequency by 75%.
• Genitourinary Syndrome of Menopause (GSM): This includes vaginal dryness, burning, pain during sex, and frequent urinary tract infections.
• Bone Loss (Osteoporosis): Menopause causes a rapid loss of bone density. Hormone therapy is approved to prevent osteoporosis and protect against bone fractures in postmenopausal women, though it is not the primary drug used to treat someone who already has severe osteoporosis.
• Premature Menopause: It is used to treat women whose ovaries stop working at an abnormally young age.

The Two Main Types of Hormone Therapy

A critical factor in prescribing hormones is whether or not a woman still has her uterus.

• Estrogen-Alone Therapy (ET): This is for women who have had a hysterectomy (their uterus was removed). They can safely take just estrogen.
• Estrogen plus Progestogen Therapy (EPT): If a woman still has her uterus, taking estrogen by itself is dangerous because it can cause the lining of the uterus to overgrow, significantly increasing the risk of endometrial (uterine) cancer. To prevent this, doctors must pair the estrogen with a "progestogen" (like progesterone), which protects the uterine lining.

How the Hormones are Delivered Matters

The statement emphasizes that how a woman takes the hormones can change her risk profile.

• Systemic Therapy (Pills, Patches, Sprays): These formulations travel through the entire bloodstream to treat full-body symptoms like hot flashes and bone loss. While oral pills are common, non-oral routes like transdermal skin patches or gels are becoming favored. Because patches are absorbed through the skin and bypass the liver, observational studies suggest they carry a lower risk of causing blood clots and gallbladder disease compared to pills.
• Local Therapy (Vaginal Creams, Tablets, or Rings): If a woman's only symptoms are vaginal dryness or pain during sex, she should not take systemic pills or patches. Instead, she should use low-dose local vaginal estrogen. Because the dose is so low, it largely stays in the vaginal tissue and barely enters the bloodstream, making it incredibly safe—so safe that she does not even need to take a progestogen alongside it.

Breaking Down the Health Risks

A major reason women fear hormone therapy is due to confusion about the risks. The NAMS statement carefully clarifies these risks to show that for most healthy, younger menopausal women, the dangers are quite rare:

Breast Cancer The risk of breast cancer is one of the biggest concerns for women, but the guidelines put this into perspective.

• For women taking Estrogen-Alone (ET): The landmark Women's Health Initiative (WHI) study actually showed that women taking estrogen alone had a lower incidence of breast cancer and a lower risk of dying from breast cancer compared to women taking a placebo.
• For women taking Estrogen plus Progestogen (EPT): There is a small, rare increase in breast cancer risk. To put this "rare" risk in plain English, the statement notes that it results in less than one additional case of breast cancer per 1,000 women per year of use. This level of risk is similar to the breast cancer risk caused by drinking two alcoholic beverages a day, being obese, or not getting enough exercise.

Heart Disease and Blood Clots

Hormone therapy is not approved to protect the heart. While starting hormone therapy early in menopause might lower the risk of heart disease and overall mortality, starting it after age 60 increases the risk of heart attacks. Furthermore, systemic hormone therapy (especially pills) does carry a rare increased risk of blood clots (venous thromboembolism) and stroke.

Dementia and Brain Health

Hormone therapy should never be prescribed to prevent or treat dementia or cognitive decline. In fact, the studies showed that if women over the age of 65 start taking combination hormone therapy (EPT), their risk of developing dementia actually doubles.

Weight Gain

Many women blame menopause and hormone therapy for weight gain. The statement notes that while midlife and menopause naturally cause women to gain about 1.5 pounds a year and shift fat to the belly area, hormone therapy does not cause this weight gain. In fact, women on hormone therapy either see no effect on their weight or gain slightly less weight than women who don't take hormones.

Special Warnings and Scenarios

The position statement makes firm recommendations regarding a few unique situations:

• Early Menopause (Premature Ovarian Insufficiency): If a woman goes through menopause before the age of 40 (naturally or due to surgery removing her ovaries), she is at a severe risk for bone loss, heart disease, dementia, and early death because she is living without estrogen for much longer than normal. The statement strongly recommends that these women take hormone therapy at least until the average age of natural menopause (around age 52) to protect their long-term health.
• "Bioidentical" Compounded Hormones: The statement gives a strict warning against using custom-compounded "bioidentical" hormones mixed by specialty pharmacies. These are marketed as "natural," but they are not regulated by the FDA, have no safety labels, can easily be overdosed or underdosed, and might contain impurities. NAMS strongly advises using only FDA-approved, government-regulated hormone treatments.

How Long Should You Stay on Hormone Therapy?

Historically, women were told they absolutely had to stop hormone therapy when they turned 65. The 2022 statement declares that this arbitrary age cutoff is outdated and not supported by science.

Many women suffer from hot flashes for a decade or more, and some suffer from them for the rest of their lives. If a woman turns 65 and is still suffering from severe symptoms that ruin her quality of life, she does not have to stop her medication. While the risks do go up slightly as she ages and stays on the medication longer, she and her doctor should have a shared conversation to reevaluate her personal health. They might decide to lower the dose, switch from an oral pill to a skin patch to lower clot risks, and continue treatment for as long as she needs it.

Menopause Society Guidelines Summary

In plain English: Hormone therapy is safe, highly effective, and beneficial for the vast majority of healthy women entering menopause in their 50s. However, it requires a custom-tailored approach. A woman and her doctor must choose the lowest effective dose, the safest delivery method (like a patch or a vaginal cream depending on the symptoms), and regularly review her health to ensure the benefits continue to outweigh any risks.